Loading…
Exploring the binding mechanisms of inorganic magnetic nanocarrier containing L-Dopa with HSA protein utilizing multi spectroscopic techniques
In this study, the interaction of Fe 3 O 4 @CaAl-LDH@L-Dopa nanoparticles (NPs) with human serum albumin (HSA) was investigated in simulated physiological conditions applying UV-visible, fluorescence, and circular dichroism (CD) spectroscopic techniques. The consequences of UV-vis and CD spectroscop...
Saved in:
Published in: | Journal of biomolecular structure & dynamics 2021-12, Vol.39 (18), p.7160-7167 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In this study, the interaction of Fe
3
O
4
@CaAl-LDH@L-Dopa nanoparticles (NPs) with human serum albumin (HSA) was investigated in simulated physiological conditions applying UV-visible, fluorescence, and circular dichroism (CD) spectroscopic techniques. The consequences of UV-vis and CD spectroscopy demonstrated that the interaction of HSA to Fe
3
O
4
@CaAl-LDH@L-Dopa NPs enforced some conformational alterations within HSA. The fluorescence spectroscopy analysis indicated that by enhancing temperature, the Stern-Volmer quenching constant (K
sv
) was decreased, which is relevant to a static quenching mechanism. The binding constant (K
b
) was 7.07 × 10
4
M
−1
while the number of the binding site (n) was 0.94 which is in compromise with its binding constant. Also, thermodynamic parameters (ΔH° > 0, ΔG° < 0, and ΔS° > 0) have suggested that hydrophobic forces perform a key role in the interaction of HSA with Fe
3
O
4
@CaAl-LDH@L-Dopa NPs. Displacement studies successfully carried out using the Warfarin and Ibuprofen have predicted that the binding of Fe
3
O
4
@CaAl-LDH@L-Dopa NPs to HSA is situated at site II (subdomain IIIA).
Communicated by Ramaswamy H. Sarma |
---|---|
ISSN: | 0739-1102 1538-0254 |
DOI: | 10.1080/07391102.2020.1806929 |